Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


Pakistan Seeks $10 Billion U.S. Exchange Stabilization Fund to Boost Forex Reserves
Lockheed Martin Unveils Lower-Cost Patriot ACE Interceptor to Meet Rising Air Defense Demand
Samsung Eyes Up to $1.14 Billion Investment in AI Startup Mistral
US Stock Futures Rise as AI Optimism Lifts Tech, 3M Jumps on Strong Earnings
Japan Yen Slides Past 163 as Middle East Tensions Lift US Dollar, Oil Prices
Nvidia Reveals 9.3% Stake in AI Cloud Firm Nebius Following $2 Billion Investment
GE Vernova Q2 Revenue Tops Estimates as Earnings Miss, Shares Slide Despite Higher 2026 Outlook
Oil Prices Hold Steady as U.S.-Iran Conflict and Houthi Blockade Keep Markets on Edge
Morgan Stanley Downgrades Adobe, Workday as AI Transition Raises Growth Concerns
Cathay Pacific Sees H1 Profit Surge on Strong Travel Demand
Japan PM Sanae Takaichi Unveils Growth Plan as BOJ Independence Concerns Lift Bond Yields
Asian Currencies Hold Steady as Middle East Tensions Boost US Dollar, Oil Concerns
Nasdaq Drops as AI Earnings, Oil Surge and Middle East Tensions Weigh on Wall Street
US Dollar Holds Near One-Week High as Middle East Tensions and Oil Prices Drive Market Sentiment
IBM Q2 Earnings Miss Estimates as Software Growth Offsets Infrastructure Weakness
Samsung Biologics Launches $1.81 Billion Bid to Acquire PolyPeptide
Super Micro Computer Stock Jumps 20% After Record AI Orders and Margin Surge 



